An Arizona drug company will patent the small peptide drug.
In a sedentary office environment, participants working in 78° to 80°F temperatures consumed nearly 90 fewer calories than those in a cooler environment.
When machines and brains mix, who's in charge? This is the type of problem pondered by neuroethicists such as UAB's Josh May, Ph.D., who examine questions at the crossroads of neuroscience and ethics.
Sorge honored as a young leader in the field of pain research and neuroscience by national organization.
Published in Faculty Excellence
Smita Bhatia, M.D., M.P.H., director of UAB's new Institute for Cancer Outcomes and Survivorship, explains how cancer treatments can lead to chronic health conditions in later life — and how "survivorship clinics" will help.
Published in Focus on Patient Care
Naloxone kits have prevented more than 10,000 deaths from opioid overdose since local distribution programs began in 1996. Now, as deaths from opioid overdose reach an all-time high in the United States, a crowdfunded project from UAB researchers aims to put naloxone in the hands of those at highest risk.
Published in Service to Community
The challenge is to stifle the binding of inhibitory antibodies but retain activity of a blood enzyme.
UAB research shows that phytoplankton, the foundation of all marine life, will experience varied growth rates due to ocean acidification levels during the next century.
Gene mastermind Shawn Levy, Ph.D., and his team at the HudsonAlpha Genomic Services Laboratory are helping UAB investigators — and researchers from around the world — crack the mysteries of life.
Haydeh Payami, Ph.D., a leading geneticist recruited to the UAB-Hudson Alpha Center for Genomic Medicine and UAB Personalized Medicine Institute, is exploring the protective power of coffee and nicotine — and the mysteries of the microbiome — in Parkinson’s disease.
Rates of vision impairment are high among seniors living in subsidized housing, suggesting an increased need for widespread vision screening.

Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
Published in Service to Community
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.
UAB’s Karan Singh has been selected as an American Statistical Association Fellow and recognized as a foremost member in the field of statistical science. 
Published in Faculty Excellence
A UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.
Published in Faculty Excellence
Male and female mice use different immune cells to process chronic pain, indicating that different therapies for different genders could better target the problem.
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
Hundreds of students will present academic pursuits in cutting-edge research topics.
Published in Student Experience
UAB offers two national clinical trials with customized treatment for lung cancer patients.
Published in Focus on Patient Care
UAB’s David Pollock, Ph.D., recently visited Cuba with a delegation from the American Physiological Society to sign a historic agreement for research collaboration with Cuban counterparts.
Published in Faculty Excellence

News You Can Use

Back to Top